Nxt-ID, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXTD research report →
Companywww.nxt-id.com
Nxt-ID, Inc. provides technology products and services for healthcare applications. It develops and markets solutions for payment, Internet of Things (IoT), and healthcare applications with experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, and sensor technologies.
- CEO
- Vincent Miceli
- IPO
- 2013
- Employees
- 19
- HQ
- Sebastian, FL, US
Price Chart
Valuation
- Market Cap
- $57.75M
- P/E
- -0.19
- P/S
- 4.79
- P/B
- 0.09
- EV/EBITDA
- -11.45
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 68.25%
- Op Margin
- -26.68%
- Net Margin
- -58.33%
- ROE
- -41.13%
- ROIC
- -19.01%
Growth & Income
- Revenue
- $11.43M · 15.39%
- Net Income
- $-7,767,427 · 16.51%
- EPS
- $-13.06 · 10.85%
- Op Income
- $-4,104,430
- FCF YoY
- -18.93%
Performance & Tape
- 52W High
- $18.30
- 52W Low
- $2.10
- 50D MA
- $2.87
- 200D MA
- $5.05
- Beta
- 1.82
- Avg Volume
- 2.46M
Get TickerSpark's AI analysis on NXTD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 31, 21 | Curtis Robert Arthur | other | 3,268 |
| Dec 31, 21 | SHARKEY DANIEL P | other | 3,268 |
| Dec 31, 21 | Gust David Richard | other | 3,268 |
| Dec 31, 21 | D'Almada-Remedios Michael | other | 3,268 |
| Dec 17, 21 | Curtis Robert Arthur | other | 4,016 |
| Dec 17, 21 | D'Almada-Remedios Michael | other | 4,016 |
| Dec 17, 21 | SHARKEY DANIEL P | other | 4,016 |
| Dec 17, 21 | Gust David Richard | other | 4,016 |
| Dec 31, 19 | D'Almada-Remedios Michael | other | 44,444 |
| Sep 30, 19 | D'Almada-Remedios Michael | other | 37,736 |
Our NXTD Coverage
We haven't published any research on NXTD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NXTD Report →